Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 5BNP | Q68T42 | Crystal structure of human enterovirus D68 in complex with 3'SLN | |
| 4UT9 | Q68Y26 | Crystal structure of dengue 2 virus envelope glycoprotein dimer in complex with the ScFv fragment of the broadly neutralizing human antibody EDE1 C10 | |
| 4UTA | Q68Y26 | Crystal structure of dengue 2 virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE1 C8 | |
| 4UTB | Q68Y26 | Crystal structure of dengue 2 virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE2 A11 | |
| 4UTC | Q68Y26 | Crystal structure of dengue 2 virus envelope glycoprotein | |
| 5N0A | Q68Y26 | Crystal structure of A259C covalently linked dengue 2 virus envelope glycoprotein dimer in complex with the Fab fragment of the broadly neutralizing human antibody EDE2 A11 | |
| 8TCO | Q69155 | HCMV Trimer in complex with CS2it1p2_F7K Fab and CS4tt1p1_E3K Fab | |
| 3W9E | Q69467 | Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD | |
| 6M18 | Q695T7 | ACE2-B0AT1 complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
| 8I92 | Q695T7 | ACE2-B0AT1 complex bound with glutamine | |
| 8I93 | Q695T7 | ACE2-B0AT1 complex bound with methionine | |
| 6M17 | Q695T7 | The 2019-nCoV RBD/ACE2-B0AT1 complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23), SARS-coV-2 Receptor Binding Domain |
| 7DWX | Q695T7 | Conformation 1 of S-ACE2-B0AT1 ternary complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
| 7V61 | Q695T7 | ACE2 -Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus Blocker | |
| 7PNM | Q696P8 | Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 46C12 antibody Fab fragment | |
| 7PNQ | Q696P8 | Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 43E6 antibody Fab fragment | |
| 7PO5 | Q696P8 | Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 47C9 antibody Fab fragment | |
| 6NZK | Q696P8 | Structural basis for human coronavirus attachment to sialic acid receptors | Spike surface glycoprotein |
| 6OHW | Q696P8 | Structural basis for human coronavirus attachment to sialic acid receptors. Apo-HCoV-OC43 S | Spike surface glycoprotein |
| 8G8A | Q69910 | Crystal structure of DH1317.8 Fab in complex with HIV proximal MPER peptide | |
| 3BL8 | Q69ZK9 | Crystal structure of the extracellular domain of neuroligin 2A from mouse | Neuroligin-2 |
| 6S9F | Q6AWJ9 | Drosophila OTK, extracellular domains 3-5 | |
| 9B8O | Q6AXS4 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo | |
| 9BRD | Q6AXS4 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3 | |
| 4RM0 | Q6B7R3 | Crystal structure of Norovirus OIF P domain in complex with Lewis a trisaccharide | |
| 5FUU | Q6BC19 | Ectodomain of cleaved wild type JR-FL EnvdCT trimer in complex with PGT151 Fab | HIV-1 ENVELOPE GLYCOPROTEIN GP160, IMMUNOGLOBULIN G PGT151 |
| 5FYK | Q6BC19 | Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade B JR-FL SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122, 35O22 and VRC01 | |
| 9BER | Q6BC19 | Cryo-EM structure of the HIV-1 JR-FL IDL Env trimer in complex with PGT122 Fab | |
| 8AB6 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
| 8AB7 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
| 8AB8 | Q6C0H4 | Complex III2, b-position, with decylubiquinone and ascorbate-reduced | |
| 8AB9 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, ascorbate-reduced, b-position | |
| 8ABA | Q6C0H4 | Complex III2 from Yarrowia lipolytica, ascorbate-reduced, int-position | |
| 8ABB | Q6C0H4 | Complex III2 from Yarrowia lipolytica, ascorbate-reduced, c-position | |
| 8ABE | Q6C0H4 | Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, b-position | |
| 8ABF | Q6C0H4 | Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, int-position | |
| 8ABG | Q6C0H4 | Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, c-position | |
| 8ABH | Q6C0H4 | Complex III2 from Yarrowia lipolytica, antimycin A bound, b-position | |
| 8ABI | Q6C0H4 | Complex III2 from Yarrowia lipolytica,antimycin A bound, int-position | |
| 8ABJ | Q6C0H4 | Complex III2 from Yarrowia lipolytica, antimycin A bound, c-position | |
| 8ABK | Q6C0H4 | Complex III2 from Yarrowia lipolytica, decylubiquinol bound, b-position | |
| 8ABL | Q6C0H4 | Complex III2 from Yarrowia lipolytica, with decylubiquinol and antimycin A, consensus refinement | |
| 8ABM | Q6C0H4 | Complex III2 from Yarrowia lipolytica, apo, b-position | |
| 8AC3 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, apo, int-position | |
| 8AC4 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, apo, c-position | |
| 8AC5 | Q6C0H4 | Complex III2 from Yarrowia lipolytica, with decylubiquinol, oxidised, b-position | |
| 8AB6 | Q6C2E3 | Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement | |
| 8AB7 | Q6C2E3 | Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound | |
| 8AB8 | Q6C2E3 | Complex III2, b-position, with decylubiquinone and ascorbate-reduced | |
| 8AB9 | Q6C2E3 | Complex III2 from Yarrowia lipolytica, ascorbate-reduced, b-position |
